Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange.
Sullivan MR et al. J Clin Apher. 2014 Nov 21. doi: 10.1002/jca.21371. [Epub ahead of print].
A case of endocapillary proliferative glomerulonephritis with macrophages phagocytosing monoclonal immunoglobulin lambda light chain.
Watanabe H et al. Pathol Int. 2014 Nov 19. doi: 10.1111/pin.12229. [Epub ahead of print].
Successful re-administration of lenalidomide after lenalidomide-induced pulmonary alveolar hemorrhage in a patient with refractory myeloma.
Sakai M et al. Ann Hematol. 2014 Nov 20. [Epub ahead of print].
Therapy-related peripheral neuropathy in multiple myeloma patients.
Morawska M et al. Hematol Oncol. 2014 Nov 14. doi: 10.1002/hon.2149. [Epub ahead of print].
Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study.
Ludwig H et al. Haematologica. 2014 Nov 14. pii: haematol.2014.115204. [Epub ahead of print].
Neutrophilic dermatosis: disease mechanism and treatment.
Maalouf D et al. Curr Opin Hematol. 2014 Nov 12. [Epub ahead of print].
Cement pulmonary embolism after percutaneous vertebroplasty in multiple myeloma.
Gorospe L et al. Asian Cardiovasc Thorac Ann. 2014 Nov 4. pii: 0218492314558521. [Epub ahead of print].
Spontaneous sternal collapse in multiple myeloma.
Pickard L et al. Br J Haematol. 2014 Nov 7. doi: 10.1111/bjh.13204. [Epub ahead of print].
Recurrence of monoclonal IgA lambda glomerulonephritis in kidney allograft associated with multiple myeloma.
Herrmann SM et al. Clin Nephrol. 2014 Nov 5. [Epub ahead of print].
Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study.
Marchesi F et al. Transpl Infect Dis. 2014 Nov 5. doi: 10.1111/tid.12309. [Epub ahead of print].
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Detrait MY et al. Bone Marrow Transplant. 2014 Nov 3. doi: 10.1038/bmt.2014.244. [Epub ahead of print].
Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents.
Gertz MA et al. Leuk Lymphoma. 2014 Nov 3:1-4. [Epub ahead of print].
Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma.
Wang XS et al. Leuk Lymphoma. 2014 Nov 20:1-7. [Epub ahead of print]